Skip to content

The David H. Koch Institute for Integrative Cancer Research At MIT

About

  • Director's Message
  • Future
  • Scientific Advisory Board
  • FAQs
  • Administration

Faculty

Research Areas

  • Nanotechnology Therapy
  • Detection and Monitoring
  • Metastasis
  • Pathways and Resistance
  • Immune System

facilities

  • The Koch Institute
  • Swanson Biotechnology Center

News and Events

  • Press Kit
  • Summer Symposium

Contact

Support

  • Make a Gift Now
  • Naming Opportunities
  • Bequests and Trusts
  • Corporate Giving
  • Gifts of Stock
  • Gifts of Other Assets

Research Areas

  • Nanotechnology Therapy
  • Detection and Monitoring
  • Metastasis
  • Pathways and Resistance
  • Immune System

A Five-Pronged Approach to Controlling Cancer

The initial strategic research plan for the Koch Institute revolves around five target areas critical for rapid progress toward controlling cancer. Research and development in each of these target areas involves cross-disciplinary teams of faculty, students, and staff – and will also encompass collaborations with clinical centers and industry.


1. Nanotechnology Therapy


2. Detection and Monitoring


3. Metastasis


4. Pathways and Resistance


5. Immune System

NCI Research Programs

Molecular Genetics and Immunology
Phillip Sharp, Program Leader

Genetics and Model Systems
Tyler Jacks, Program Leader

Cell Biology
Richard Hynes, Program Leader